2024-05-06 21:31:02 ET
Vertex Pharmaceuticals, Inc. (VRTX)
Q1 2024 Earnings Conference Call
May 06, 2024, 16:30 ET
Company Participants
Susie Lisa - SVP, IR
Reshma Kewalramani - CEO, President & Director
Stuart Arbuckle - EVP & COO
Charles Wagner - EVP & CFO
Conference Call Participants
Geoff Meacham - Bank of America Merrill Lynch
Jessica Fye - JPMorgan Chase & Co.
Salveen Richter - Goldman Sachs Group
Olivia Brayer - Cantor Fitzgerald & Co.
Liisa Bayko - Evercore ISI
Terence Flynn - Morgan Stanley
Debjit Chattopadhyay - Guggenheim Securities
Evan Seigerman - BMO Capital Markets
Philip Nadeau - TD Cowen
Colin Bristow - UBS
Presentation
Operator
Good day, and welcome to the Vertex Pharmaceuticals First Quarter 2024 Earnings Conference Call. [Operator Instructions].
I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead.
Susie Lisa
Good evening all. My name is Susie Lisa, and as the Senior Vice President of Investor Relations. It is my pleasure to welcome you to our first quarter 2024 financial results conference call.
On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Operating Officer; and Charlie Wagner, Chief Financial Officer....
Read the full article on Seeking Alpha
For further details see:
Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript